// App-Quantinova.ai

: Familial Predisposition to B-Cell Precursor Acute Lymphoblastic Leukemia Mediated By PAX5 Germline Variants

Researchers

Presenter

  • Franziska Auer

Principal Investigators

  • Adela Escuerdo

  • Ulrike Anne Friedrich

  • Polina Stepensky

  • Arndt Borkhardt

  • Sarah Elitzur

  • Masatoshi Takagi

  • Julia Hauer

Medical Centers

  • Technical University of Munich, School of Medicine, Department of Pediatrics, Munich, Germany

  • Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan

  • Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany

  • Pediatric Hematology and Oncology, Schneider Children's Medical Center and Tel Aviv University, Tel Aviv, Israel

  • Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel

  • Institute of Medical and Molecular Genetics (INGEMM) La Paz University Hospital, Madrid, Spain

Locations

  • Germany

  • Japan

  • Israel

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Paired box 5

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved